Evidence map›Paper›PMID 20152939›Full record

ArticleBiochimica et biophysica acta2010

Beta sheet 2-alpha helix C loop of cytochrome P450 reductase serves as a docking site for redox partners.

Hyun-Hee Jang, Arvind P Jamakhandi, Shane Z Sullivan, Chul-Ho Yun, Paul F Hollenberg, Grover P Miller

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Functional Characterization of 21 Rare AllelicJournal of personalized medicine · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Solution structure of the cytochrome P450 reductase-cytochromeThe Journal of biological chemistry · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hyun-Hee JangSchool of Biological Sciences and Technology and Hormone Research Center, Chonnam National University, Gwangju 500-757, Republic of Korea.
Arvind P Jamakhandi
Shane Z Sullivan
Chul-Ho Yun
Paul F Hollenberg
Grover P Miller
University of Arkansas for Medical Sciences · USChonnam National University · KRUniversity of Michigan–Ann Arbor · US

Funding

Structure based drug discoveryP20RR015569 · NCRR · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2000 to 2009
$21.4M
HEMOPROTEIN-CATALYZED OXYGENATIONS OF CARCINOGENSR01CA016954 · NCI · WAYNE STATE UNIVERSITY · PI HOLLENBERG, PAUL F. · 1986 to 2011
$4.3M
NCI NIH HHS R01 CA016954NCRR NIH HHS 1 P20 RR015569-06NCRR NIH HHS P20 RR015569
6 · The paper itself

Abstract

As a promiscuous redox partner, the biological role of cytochrome P450 reductase (CPR) depends significantly on protein-protein interactions. We tested a hypothesized CPR docking site by mutating D113, E115, and E116 to alanine and assaying activity toward various electron acceptors as a function of ionic strength. Steady-state cytochrome c studies demonstrated the mutations improved catalytic efficiency and decreased the impact of ionic strength on catalytic parameters when compared to wild type. Based on activity toward 7-ethoxy-4-trifluoro-methylcoumarin, CYP2B1 and CPR favored formation of an active CYP2B1*CPR complex and inactive (CYP2B1)(2)*CPR complex until higher ionic strength whereby only the binary complex was observed. The mutations increased dissociation constants only for the binary complex and suppressed the ionic strength effect. Studies with a non-binding substrate, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) suggest changes in activity toward cytochrome c and CYP2B1 reflect alterations in the route of electron transfer caused by the mutations. Electrostatic modeling of catalytic and binding parameters confirmed the importance of D113 and especially the double mutant E115 and E116 as mediators in forming charge-charge interactions between CPR and complex partners.

Indexed as

Models, MolecularAmino Acid SubstitutionAnimalsCatalysisCattleCytochrome P-450 CYP2B1Cytochromes cHorsesMutation, MissenseNADPH-Ferrihemoprotein ReductaseOsmolar ConcentrationOxidation-ReductionProtein BindingProtein Structure, QuaternaryProtein Structure, SecondaryStatic ElectricityCytochrome P-450 CYP2B1Cytochromes cNADPH-Ferrihemoprotein Reductase

Identifiers

PMID20152939
PMCPMC2847005
OpenAlexW2087329318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.